Edesa Biotech, Inc. (EDSA) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
100 SPY COURT MARKHAM, |
| State of Incorp. | BC |
| Fiscal Year End | September 30 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2025 MRQ | 9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 10,800 | 1,000 | 5,400 | 7,091 | 7,839 | 7,214 | |||
| Cash and cash equivalent | 10,800 | 1,000 | 5,400 | 7,091 | 7,839 | 7,214 | |||
| Receivables | 3,303 | 87 | |||||||
| Other undisclosed current assets | 713 | 676 | 1,037 | 2,001 | 949 | 803 | |||
| Total current assets: | 11,513 | 1,676 | 6,437 | 9,092 | 12,091 | 8,104 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 18 | 91 | 18 | 97 | 160 | ||||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 9 | 13 | 15 | 15 | |||||
| Intangible asset, including goodwill, after accumulated amortization | 1,978 | 2,079 | 2,180 | 2,281 | 2,382 | 2,484 | |||
| Intangible asset, excluding goodwill, after accumulated amortization | 1,978 | 2,079 | 2,180 | 2,281 | 2,382 | 2,484 | |||
| Deposits noncurrent assets | 40 | 41 | 173 | ||||||
| Other undisclosed noncurrent assets | 171 | ||||||||
| Total noncurrent assets: | 2,018 | 2,138 | 2,454 | 2,484 | 2,494 | 2,658 | |||
| TOTAL ASSETS: | 13,531 | 3,814 | 8,890 | 11,576 | 14,585 | 10,762 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1,079 | 1,813 | 1,747 | 2,122 | 1,380 | 1,460 | |||
| Accrued liabilities | 15 | 22 | |||||||
| Other undisclosed accounts payable and accrued liabilities | 1,079 | 1,813 | 1,732 | 2,100 | 1,380 | 1,460 | |||
| Debt | 70 | ||||||||
| Other undisclosed current liabilities | 20 | 75 | 19 | 79 | |||||
| Total current liabilities: | 1,079 | 1,833 | 1,822 | 2,141 | 1,459 | 1,530 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 44 | 21 | 94 | ||||||
| Long-term debt, excluding current maturities | 44 | ||||||||
| Liabilities, other than long-term debt | 20 | 47 | 30 | ||||||
| Accounts payable and accrued liabilities | 47 | 30 | |||||||
| Operating lease, liability | 20 | 21 | 94 | ||||||
| Total noncurrent liabilities: | 20 | 44 | 68 | 124 | |||||
| Total liabilities: | 1,079 | 1,833 | 1,842 | 2,184 | 1,526 | 1,654 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 12,452 | 1,981 | 7,049 | 9,391 | 13,058 | 6,631 | |||
| Common stock | 54,515 | 47,236 | 34,888 | 18,501 | |||||
| Additional paid in capital | 14,753 | 13,577 | 13,039 | 11,176 | 4,871 | 1,550 | |||
| Accumulated other comprehensive loss | (166) | (243) | (215) | (214) | (205) | (287) | |||
| Accumulated deficit | (65,911) | (58,589) | (52,419) | (44,045) | (26,496) | (13,133) | |||
| Other undisclosed equity, attributable to parent | 9,260 | 46,643 | 42,473 | ||||||
| Other undisclosed equity | 2,477 | ||||||||
| Total equity: | 12,452 | 1,981 | 7,049 | 9,391 | 13,058 | 9,108 | |||
| TOTAL LIABILITIES AND EQUITY: | 13,531 | 3,814 | 8,890 | 11,576 | 14,585 | 10,762 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2025 TTM | 9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 780 | 10,340 | 329 | |||||
| Operating lease, lease income | 780 | 10,340 | ||||||
| Cost of revenue | (101) | (18) | ||||||
| Deferred sales inducement cost, amortization expense | (101) | |||||||
| Gross profit: | 780 | 10,239 | 311 | |||||
| Operating expenses | (7,912) | (7,015) | (9,223) | (18,371) | (23,681) | (6,730) | ||
| Other undisclosed operating income (loss) | (780) | (10,239) | 18 | |||||
| Operating loss: | (7,912) | (7,015) | (9,223) | (18,371) | (23,681) | (6,401) | ||
| Nonoperating income (expense) | 727 | 845 | 849 | (21) | 10,339 | 37 | ||
| Investment income, nonoperating | 38 | |||||||
| Loss, foreign currency transaction, before tax | (60) | (21) | (22) | (21) | (0) | |||
| Government assistance, nonoperating income, increase (decrease) | 784 | 698 | ✕ | ✕ | ✕ | ✕ | ||
| Interest and debt expense | 15 | |||||||
| Loss from continuing operations before equity method investments, income taxes: | (7,185) | (6,154) | (8,374) | (18,392) | (13,342) | (6,363) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (15) | 844 | ||||||
| Loss from continuing operations before income taxes: | (7,185) | (6,169) | (8,374) | (17,548) | (13,342) | (6,363) | ||
| Income tax expense | (1) | (1) | (1) | (1) | (1) | (1) | ||
| Loss from continuing operations: | (7,186) | (6,170) | (8,374) | (17,549) | (13,343) | (6,364) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (17,549) | (13,343) | (6,364) | |
| Other undisclosed net income | 16,749 | 35,098 | ||||||
| Net income (loss): | (7,186) | (6,170) | 8,374 | 17,549 | (13,343) | (6,364) | ||
| Other undisclosed net income (loss) attributable to parent | (16,749) | (35,098) | 1 | |||||
| Net loss available to common stockholders, diluted: | (7,186) | (6,170) | (8,374) | (17,549) | (13,342) | (6,364) | ||
Comprehensive Income ($ in thousands)
| 12/31/2025 TTM | 9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (7,186) | (6,170) | 8,374 | 17,549 | (13,343) | (6,364) | ||
| Other comprehensive loss | (17,557) | (773) | ||||||
| Comprehensive income (loss): | (7,186) | (6,170) | 8,374 | (8) | (14,116) | (6,364) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 77 | (28) | (16,750) | (17,549) | 855 | 55 | ||
| Comprehensive loss, net of tax, attributable to parent: | (7,109) | (6,198) | (8,375) | (17,557) | (13,261) | (6,309) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.